What Is Arveles Medicine Used For?

Arveles is a brand name for dexketoprofen trometamol, a nonsteroidal anti-inflammatory drug (NSAID) prescribed for short-term relief of mild to moderate pain. It works faster and at lower doses than many related painkillers because its active ingredient is the purified, pharmacologically active half of the older drug ketoprofen. Arveles is widely used across Europe, Turkey, and parts of Asia and Latin America for conditions ranging from dental pain and menstrual cramps to acute low back pain, though it remains less familiar in markets where ibuprofen and naproxen dominate pharmacy shelves.

What Dexketoprofen Actually Is

Many older NSAIDs are sold as a 50/50 mixture of two mirror-image molecules. One mirror image does the pain-relieving work; the other is essentially inactive baggage. Ketoprofen is one of those drugs. Its pain-relieving activity comes entirely from the S(+) mirror image, called dexketoprofen, while the R(−) mirror image contributes nothing to pain relief.¹ By isolating just the active half and pairing it with a trometamol salt to improve solubility, the makers of Arveles created a drug that delivers the same analgesic punch at roughly half the weight of racemic ketoprofen. That matters because a lower total drug load means less material passing through your stomach lining and kidneys for the same therapeutic benefit.

How Arveles Relieves Pain

Like other NSAIDs, dexketoprofen blocks the enzymes (cyclooxygenase-1 and cyclooxygenase-2) that produce prostaglandins, the chemicals your body releases at sites of injury or inflammation to amplify pain signals. Ketoprofen has long been recognized as one of the most potent prostaglandin-synthesis inhibitors in its class, and that potency carries over to dexketoprofen.²

What sets dexketoprofen apart from a typical “peripheral-only” painkiller is evidence that it also acts inside the central nervous system. Animal research found that when applied directly to the spinal cord, dexketoprofen suppressed pain-related nerve responses at doses in the same range as the powerful opioid fentanyl.³ That does not mean it works like an opioid in everyday clinical use, but it suggests the drug has central pain-dampening properties beyond simple inflammation reduction. A study of patients undergoing hip replacement surgery confirmed that dexketoprofen crosses into cerebrospinal fluid rapidly, appearing there within about 30 minutes of administration.⁴

Speed of Onset and Duration

One of Arveles’s selling points is how quickly it kicks in. In tablet form, dexketoprofen trometamol reaches peak blood levels in roughly 15 to 45 minutes. That is noticeably faster than taking the same active molecule bundled inside regular ketoprofen tablets or capsules, where the peak can take anywhere from 30 minutes to 3 hours.⁵ The trometamol salt form dissolves more readily in the gut, which explains the speed advantage. In clinical trials, patients with dental pain reported meaningful relief within 30 minutes of swallowing a 25 mg tablet, and that relief lasted about six hours.⁶

For people who struggle with tablets, pharmaceutical researchers have also been developing orally disintegrating granules that dissolve on the tongue. The challenge with that format is that dexketoprofen trometamol tastes bitter and produces a burning sensation, so taste-masking technology is needed to make it palatable.⁷

What Kinds of Pain It Treats

Arveles is prescribed across a surprisingly wide range of acute pain scenarios. The strongest evidence clusters around a few common conditions.

Dental and Post-Surgical Pain

Wisdom tooth extraction is one of the most studied pain models in pharmacology because it produces predictable, moderate-to-severe pain in otherwise healthy people. A randomized trial of 210 patients found that dexketoprofen trometamol at 25 mg was at least as effective as 50 mg of racemic ketoprofen for post-extraction dental pain, with a faster onset of action.⁸ A more recent systematic review and meta-analysis of multiple trials confirmed that 25 mg of dexketoprofen trometamol provided significantly better pain relief than comparator analgesics at six hours after third molar surgery.⁹

Menstrual Pain

In an emergency-department trial comparing intravenous dexketoprofen to intravenous paracetamol (acetaminophen) for period pain, both drugs reduced pain effectively within 15 and 30 minutes. Dexketoprofen produced a slightly larger drop in pain scores at both time points, though the researchers noted the difference, while statistically real, was small enough that it probably would not feel meaningful to an individual patient.¹⁰

Low Back Pain

Acute low back pain is another common reason Arveles gets prescribed. A comparative emergency-department study found that intravenous dexketoprofen, paracetamol, and morphine all achieved large pain reductions at 30 minutes, and no single drug clearly beat the others overall.¹¹ A separate study found that dexketoprofen reduced both pain and disability in patients with non-traumatic low back pain, and the effect was amplified when combined with a steroid injection.¹²

Post-Operative Pain After Major Surgery

When given intravenously after orthopaedic surgery, dexketoprofen matched the analgesic performance of full-dose racemic ketoprofen.¹³ In a trial of patients recovering from lumbar disc surgery who were also using a morphine pump, adding dexketoprofen significantly lowered pain intensity over 24 hours compared to morphine alone, whereas adding paracetamol did not produce a statistically significant improvement.¹⁴ That finding is consistent with the broader trend in acute pain management: NSAIDs and opioids work through different pathways, so layering them together tends to produce better results than either alone.

How It Stacks Up Against Other Painkillers

One of the questions people ask most about Arveles is whether it is actually stronger than what they can already buy over the counter. The honest answer depends on the pain type, but the evidence tells a consistent story: dexketoprofen at 25 mg performs roughly on par with 50 mg of racemic ketoprofen and is at least as effective as standard doses of paracetamol and ibuprofen for acute pain, often with a faster onset. In the dental pain trial discussed above, 25 mg of dexketoprofen matched 50 mg of ketoprofen, meaning you get the same relief from half the drug weight.¹⁵

When stacked against morphine for acute back pain in the emergency setting, dexketoprofen held its own: morphine achieved a slightly larger pain reduction at 30 minutes, but the overall conclusion was that neither drug was clearly superior to the other.¹⁶ That comparison is notable because morphine is the classic benchmark for strong pain relief, and an NSAID holding its ground in a head-to-head trial speaks to dexketoprofen’s potency for certain acute conditions.

The Tramadol Combination

In several countries, dexketoprofen is available in a fixed-dose combination tablet with tramadol, a weak opioid. The logic behind the pairing is that the two drugs hit pain through entirely different mechanisms: dexketoprofen blocks prostaglandin production at the site of injury and within the central nervous system, while tramadol acts on opioid receptors in the spinal cord and modulates descending pain-control pathways.¹⁷

Clinical trial data showed that adding tramadol to dexketoprofen produced both a higher peak of pain relief and longer-lasting relief, with the advantage over dexketoprofen alone becoming most obvious after six hours.¹⁸ A separate randomized trial in dental extraction patients found that the combination provided higher pain relief scores at 6 and 36 hours compared to ibuprofen alone, even though raw pain intensity scores were similar between groups at most time points.¹⁹ The combination is typically reserved for moderate-to-severe acute pain where a single agent is not enough, and it is meant for short-term use only.

Side Effects and Safety Profile

Arveles shares the standard NSAID side-effect profile: the main risks involve the stomach, kidneys, and cardiovascular system. However, the evidence suggests it may be somewhat gentler on the gut than racemic ketoprofen. In preclinical studies, the trometamol salt form of dexketoprofen caused less gastric ulceration than the free acid form or the racemate after repeated dosing. In single-dose studies, dexketoprofen showed no significant intestinal damage at tested doses, whereas racemic ketoprofen at equivalent doses clearly produced small-bowel ulcers in the same model.²⁰ In clinical trials, the rate of reported side effects with dexketoprofen trometamol was similar to placebo.

When given by injection, the most common complaint is pain at the injection site. In a study comparing intramuscular dexketoprofen to intramuscular diclofenac after hernia repair surgery, about a quarter of dexketoprofen patients reported injection-site pain, compared with roughly a fifth in the diclofenac group, a difference that was not statistically significant.²¹ Other occasional side effects include nausea, vomiting, dizziness, and headache, all typical of the NSAID class.

For the emergency-department low back pain trial comparing dexketoprofen, paracetamol, and morphine, adverse events occurred in about 9% of dexketoprofen patients, the same rate as paracetamol and lower than the 16% seen with morphine.²²

Kidney Function and Who Should Be Cautious

All NSAIDs can stress the kidneys because prostaglandins help maintain blood flow to those organs. Blocking prostaglandin production, even briefly, can reduce kidney perfusion. Dexketoprofen is no exception. An animal study found that dexketoprofen, along with other tested NSAIDs, caused detectable changes in kidney tissue compared to untreated controls.²³

In people with mildly or moderately impaired kidneys, dexketoprofen’s peak blood concentration increases by roughly 22% and 37%, respectively, compared to people with healthy kidneys. Other measures of how the body handles the drug, such as the total amount absorbed and how fast it is cleared, did not change significantly with mild impairment. However, the kidneys’ ability to excrete certain breakdown products of the drug declined. Based on these findings, a dose reduction is recommended for anyone with impaired kidney function.²⁴ The drug is generally contraindicated in people with severe kidney disease, as with other NSAIDs.

People with active stomach ulcers, bleeding disorders, severe heart failure, or aspirin-sensitive asthma should also avoid Arveles. Pregnant women in the third trimester should not take it, and use is discouraged during earlier pregnancy as well unless specifically advised by a doctor. The standard guidance applies: take the lowest effective dose for the shortest time necessary.

Use in Children

Dexketoprofen is generally licensed for adults. Its safety and efficacy in children have not been established through large dedicated trials. Broader evidence on NSAIDs in pediatric settings shows that the class as a whole tends to provide pain relief comparable to opioids with a similar or lower rate of side effects. A review of pediatric studies on related NSAIDs (ibuprofen, ketoprofen, ketorolac, and diclofenac) found that NSAID use reduced the need for opioids in the majority of studies and delivered equivalent or better pain scores in nearly all of them.²⁵ That said, the review did not specifically include dexketoprofen, so extrapolating from closely related drugs is the best available data. If a doctor prescribes it off-label for an adolescent, the dose is typically adjusted downward.

Photosensitivity with Topical Dexketoprofen

Dexketoprofen is available in some countries as a topical gel for localized pain. While the oral and injectable forms are not associated with sun-related skin reactions, the gel is a different story. Case reports have documented photoallergic contact dermatitis in patients who applied topical dexketoprofen and then exposed the treated area to sunlight.²⁶ In one reported case, a skin eruption developed on a sun-exposed area after about a week of continuous topical use. Patch testing confirmed the reaction was caused by dexketoprofen and showed cross-reactivity with related ketoprofen-family compounds. The likely culprit is a benzophenone structure within the molecule that absorbs UV light and triggers an immune response in the skin.²⁷ If you use the topical gel form, covering the application site or avoiding direct sun exposure on that area is a sensible precaution. The reaction is uncommon, but it can be intense and slow to resolve once triggered. People who have previously reacted to topical ketoprofen are at higher risk and should generally avoid topical dexketoprofen as well.